Literature DB >> 10203371

Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients.

G Metry1, B Wikström, S Valind, B Sandhagen, T Linde, S Beshara, B Långström, B G Danielson.   

Abstract

Full correction of anemia with recombinant human erythropoietin (rhEPO) has been reported to reduce the risk of cardiovascular morbidity and mortality and improve the quality of life in hemodialysis (HD) patients. Effects of normalization of hematocrit on cerebral blood flow and oxygen metabolism were investigated by positron emission tomography. Regional cerebral blood flow (rCBF), cerebral blood volume (rCBV), oxygen extraction ratio (rOER), and metabolic rate for oxygen (rCMRO2) were measured in seven HD patients before and after correction of anemia and compared with those in six healthy control subjects. In addition, blood rheology before and on rhEPO therapy was measured in HD patients, which included blood viscosity, plasma viscosity, erythrocyte fluidity, and erythrocyte aggregability. The results showed that plasma viscosity was high (1.51+/-0.19 mPa x s) and erythrocyte fluidity was low (85.8+/-4.8 Pa(-1) x s(-1)), while whole blood viscosity was within the normal range (3.72+/-0.38 mPa x s) before rhEPO therapy. After treatment, the hematocrit rose significantly from 29.3+/-3.3 to 42.4+/-2.2% (P<0.001), accompanied by a significant increase in the whole blood viscosity to 4.57+/-0.16 mPa x s, nonsignificant decrease in erythrocyte fluidity to 79.9+/-7.4 mPa(-1) x s(-1) and nonsignificant change in plasma viscosity (1.46+/-1.3 mPa x s). Positron emission tomography measurements revealed that by normalization of hematocrit, rCBF significantly decreased from 65+/-11 to 48+/-12 ml/min per 100 cm3 (P<0.05). However, arterial oxygen content (caO2) significantly increased from 5.7+/-0.7 to 8.0+/-0.4 mmol/L (P<0.0001), rOER of the hemispheres significantly increased from 44+/-3 to 51+/-6% (P<0.05) and became significantly higher than healthy control subjects (P<0.05). In addition, rCBV significantly increased from 3.5+/-0.5 to 4.6+/-0.6 ml/100 cc brain tissue. The results showed that oxygen supply to the brain tissue increased with normalization of hematocrit, but it was accompanied by increased oxygen extraction in the brain tissue. This may be assumed to be related to the decrease of erythrocyte velocity in the cerebral capillaries as a result of the decreased blood deformability and the increased plasma viscosity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203371     DOI: 10.1681/ASN.V104854

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Optimal hematocrit based on regional cerebral blood flow in hemodialysis patients with diabetic nephropathy.

Authors:  Tsuneyoshi Oh; Osamu Sakayori; Chisako Kamano; Yuichi Komaba; Yasuhiko Iino; Yasuo Katayama
Journal:  Clin Exp Nephrol       Date:  2002-09       Impact factor: 2.801

3.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 4.  Integrative regulation of human brain blood flow.

Authors:  Christopher K Willie; Yu-Chieh Tzeng; Joseph A Fisher; Philip N Ainslie
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

5.  Hemodialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients.

Authors:  Harmke A Polinder-Bos; David Vállez García; Johanna Kuipers; Jan Willem J Elting; Marcel J H Aries; Wim P Krijnen; Henk Groen; Antoon T M Willemsen; Peter J van Laar; Fijanne Strijkert; Gert Luurtsema; Riemer H J A Slart; Ralf Westerhuis; Ron T Gansevoort; Carlo A J M Gaillard; Casper F M Franssen
Journal:  J Am Soc Nephrol       Date:  2018-03-01       Impact factor: 10.121

6.  Patterns of regional cerebral blood flow associated with low hemoglobin in the Baltimore Longitudinal Study of Aging.

Authors:  Rebecca F Gottesman; Jitka Sojkova; Lori L Beason-Held; Yang An; Dan L Longo; Luigi Ferrucci; Susan M Resnick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-05-02       Impact factor: 6.053

Review 7.  Intradialytic Cerebral Hypoperfusion as Mechanism for Cognitive Impairment in Patients on Hemodialysis.

Authors:  Dawn F Wolfgram
Journal:  J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 10.121

8.  Effect of haemodialysis on retinal circulation in patients with end stage renal disease.

Authors:  T Nagaoka; Y Takeyama; S Kanagawa; K Sakagami; F Mori; A Yoshida
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

9.  Morbidity and mortality in children with anemia at initiation of dialysis.

Authors:  Bradley A Warady; Martin Ho
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

Review 10.  Past, present and future of erythropoietin use in the elderly.

Authors:  Angel L M de Francisco; Gema Fernandez Fresnedo; Emilio Rodrigo; Celestino Piñera; Milagros Heras; Rosa Palomar; Juan C Ruiz; Manuel Arias
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.